Art Therapy as a Nursing Intervention for Individuals With Schizophrenia.
Latife Utas-Akhan, Dilek Avci, Ilkay Basak
https://pubmed.ncbi.nlm.nih.gov/37956349Actively Recruiting
Led by Kutahya Health Sciences University · Updated on 2026-01-30
17
Participants Needed
1
Research Sites
6 weeks
Total Duration
Researchers are studying the effects of clay therapy, a form of art therapy, on people with schizophrenia who are already receiving medication. Schizophrenia is a chronic mental illness that can cause symptoms like delusions and hallucinations, as well as difficulties in daily functioning. This trial aims to see if clay therapy can help improve functional recovery and social and individual performance in patients who are in remission and compliant with treatment. Participants will be randomly assigned to one of two groups. One group will receive clay therapy sessions alongside their usual pharmacological treatments, while the other group will continue with their routine therapies alone. The study will last for 12 weeks, during which the effects of clay therapy on patients' functional recovery and social performance will be evaluated. Throughout the study, participants will be assessed using the Functional Recovery Scale for Schizophrenia Patients and the Individual and Social Performance Scale to measure changes in their condition. The trial includes regular monitoring of treatment compliance and disease awareness, and participation will involve attending clay therapy sessions if assigned to the experimental group. The study is led by Kutahya Health Sciences University and aims to better understand how art therapy may support recovery in schizophrenia.
CONDITIONS
Clay Therapy in Schizophrenia Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive clay therapy sessions in addition to their routine pharmacological treatment over the course of the study.
Weekly visits for up to 12 weeks
Total: 1 location
1
Kutahya Health Sciences University
Kütahya, Kütahya, Turkey (Türkiye)
Actively Recruiting
E
Esra Karabulut
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Latife Utas-Akhan, Dilek Avci, Ilkay Basak
https://pubmed.ncbi.nlm.nih.gov/37956349Seda Karakaya Cataldas, Nurhan Eren, Neşe Üstün...
https://pubmed.ncbi.nlm.nih.gov/39808488Zenovia Ursuliak, Jean Hughes, Candice E Crocker...
https://pubmed.ncbi.nlm.nih.gov/31692270A Taksal, P M Sudhir, Keshav Kumar Janakiprasad...
https://pubmed.ncbi.nlm.nih.gov/26277224